Host Genomics in Infectious Diseases
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Understanding mechanisms by which genetic variants predispose to complications of infectious diseases can lead to important benefits including the development of biomarkers to prioritize vaccination or prophylactic therapy. Family studies, candidate genes in animal models, and the absence of well-defined risks where the complications are rare all can point to genetic predisposition. The most common approach to assessing genetic risk is to conduct an association study, which is a case control study using either a candidate gene approach or a genome wide approach. Although candidate gene variants may focus on potentially causal variants, because other variants across the genome are not tested these studies frequently cannot be replicated. Genome wide association studies need a sizable sample and usually do not identify causal variants but variants which may be in linkage disequilibrium to the actual causal variant. There are many pitfalls that can lead to bias in such studies, including misclassification of cases and controls, use of improper phenotypes, and genotyping errors. These studies have been limited to common genes and rare variants may not be detected. As the use of next generation sequencing becomes more common, it can be anticipated that more variants will be confirmed. The purpose of this review article is to address the issue of genomics in infectious diseases with an emphasis on the host. Although there are a plentitude of studies that focus on the molecular characteristics of pathogens, there are far fewer studies that address the role of human genetics in the predisposition to infection or more commonly its complications. This paper will review both the approaches used to study host genetics in humans and the pitfalls associated with some of these methods. The focus will be on human disease and therefore discussion of the use of animal models will be limited to those where there are genes that have been replicated in humans. The paper will focus on common genetic variants that account for complex traits such as infectious diseases using examples from flaviviruses.
Abstract
Understanding mechanisms by which genetic variants predispose to complications of infectious diseases can lead to important benefits including the development of biomarkers to prioritize vaccination or prophylactic therapy. Family studies, candidate genes in animal models, and the absence of well-defined risks where the complications are rare all can point to genetic predisposition. The most common approach to assessing genetic risk is to conduct an association study, which is a case control study using either a candidate gene approach or a genome wide approach. Although candidate gene variants may focus on potentially causal variants, because other variants across the genome are not tested these studies frequently cannot be replicated. Genome wide association studies need a sizable sample and usually do not identify causal variants but variants which may be in linkage disequilibrium to the actual causal variant. There are many pitfalls that can lead to bias in such studies, including misclassification of cases and controls, use of improper phenotypes, and genotyping errors. These studies have been limited to common genes and rare variants may not be detected. As the use of next generation sequencing becomes more common, it can be anticipated that more variants will be confirmed. The purpose of this review article is to address the issue of genomics in infectious diseases with an emphasis on the host. Although there are a plentitude of studies that focus on the molecular characteristics of pathogens, there are far fewer studies that address the role of human genetics in the predisposition to infection or more commonly its complications. This paper will review both the approaches used to study host genetics in humans and the pitfalls associated with some of these methods. The focus will be on human disease and therefore discussion of the use of animal models will be limited to those where there are genes that have been replicated in humans. The paper will focus on common genetic variants that account for complex traits such as infectious diseases using examples from flaviviruses.
참고문헌 (30)
- Sedyaningsih ER, "Epidemiology of cases of H5N1 virus infectionin Indonesia, July 2005-June 2006", J Infect Dis, 196, pp.522~527 (2007)
- Kandun IN, "Three Indonesian clusters of H5N1 virusinfection in 2005", N Engl J Med, 355, pp.2186~2194 (2006)
- Horby P, "What is the evidence of a role for hostgenetics in susceptibility to influenza A", H5N1, 2010, pp.138, 1550~1558
- Sørensen TI, "Geneticand environmental influences on premature deathin adult adoptees", N Engl J Med, 318, pp.727~732 (1988)
- Albright FS, "Cannon AlbrightLA. Evidence for a heritable predisposition to deathdue to influenza", J Infect Dis, 197, pp.18~24 (2008)
- Petersen LR, "West Nile virus in the America", Med Clin North Am, 92, pp.1307~1322 (2008)
- Gubler DJ, "The continuing spread of West Nile virus in thewestern hemisphere", Clin Infect Dis, 45, pp.1039~1046 (2007)
- Halstead SB, "The burden of dengueinfection", Lancet, 369, pp.1410~1411 (2007)
- "Dengue and dengue haemorrhagic fever. Fact sheet No. 117. Geneva." (2013)[URL]
- "Scientific working group report on dengue. Geneva" (2006)[URL]
- Gibbons RV, "Dengue: an escalating problem", BMJ, 324, pp.1563~1566 (2002)
- Mashimo T, "A nonsense mutation in the gene encoding 2'-5'-oligoadenylatesynthetase", L1 isoform is associated withWest Nile virus susceptibility in laboratory mice, 2002, pp.99, 11311~11316
- Prando C, "Inherited IL-12 p40 deficiency: genetic, immunologic, and clinical features of 49 patients from 30 kindreds", Medicine(Baltimore), 92, pp.109~122 (2013)
- Edeer Karaca N, "Granulomatous skin lesions, severe scrotal andlower limb edema due to mycobacterial infections in achild with complete IFN-γ receptor-1 deficiency", Immunotherapy, 11, pp.1121~1127 (2012)
- Lafaille FG, "Impaired intrinsic immunity to HSV-1 inhuman iPSC-derived TLR3-deficient CNS cells", Nature, 491, pp.769~773 (2012)
- Roy S, "Association of vitamin D receptor genotype withleprosy type", J Infect Dis, 179, pp.187~191 (1999)
- Bellamy R, "Tuberculosis and chronic hepatitis Bvirus infection in Africans and variation in the vitamin Dreceptor gene", J Infect Dis, 179, pp.721~724 (1999)
- Loke H, "Susceptibility to dengue hemorrhagic fever in vietnam:evidence of an association with variation in the vitamind receptor and Fc gamma receptor IIa genes", Am J Trop Med Hyg, 67, pp.102~106 (2002)
- Khor CC, "Genome-wide association study identifies susceptibility locifor dengue shock syndrome at MICB and PLCE1", NatGenet, 43, pp.1139~1141 (2011)
- Loeb M, "Geneticvariants and susceptibility to neurological complicationsfol lowing West Ni le vi rus infect ion", J Infect Dis, 204, pp.1031~1037 (2011)
- Ioannidis JP, "Correction of phenotypemisclassification based on high-discrimination geneticpredictive risk models", Epidemiology, 23, pp.902~909 (2012)
- Pearson TA, "How to interpret a genome-wideassociation study", JAMA, 299, pp.1335~1344 (2008)
- Marchini J, "The effectsof human population structure on large genetic associationstudies", Nat Genet, 36, pp.512~517 (2004)
- Bigham AW, "Host genetic risk factorsfor West Nile virus infection and disease progression", PLoS One, 6, pp.e24745~ (2011)
- Lim JK, "Genetic variationin OAS1 is a risk factor for initial infection with West Nilevirus in man", PLoS Pathog, 5, pp.e1000321~ (2009)
- Bigham AW, "Host genetic risk factorsfor West Nile virus infection and disease progression", PLoS One, 6, pp.e24745~ (2011)
- Glass WG, "CCR5 deficiency increases risk of symptomatic West Nile virus infection", J Exp Med, 203, pp.35~40 (2006)
- Lim JK, "Genetic deficiency of chemokinereceptor CCR5 is a strong risk factor for symptomaticWest Nile virus infection: a meta-analysis of 4 cohortsin the US epidemic", J Infect Dis, 197, pp.262~265 (2008)
- Lim JK, "CCR5 deficiency isa risk factor for early clinical manifestations of West Nilevirus infection but not for viral transmission", J Infect Dis, 201, pp.178~185 (2010)
- Metzker ML, "Sequencing technologies - the next generation", Nat Rev Genet, 11, pp.31~46 (2010)